Mutation in breast cancer
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2021/09/036282
- Lead Sponsor
- Drashti Rao Self sponsor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with pre-existing breast cancer
A patient who has complete clinicopathological data.
A patient who will have sufficient blood samples for DNA analysis.
Exclusion Criteria
There is no exclusion criteria for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate rate of TP53 gene mutation in breast cancer patient of Sir T Hospital, Bhavnagar <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 2 years <br/ ><br> <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.To assess the association with family history, menopause, age and environmental factor. <br/ ><br>2.To correlate with other blood investigation (CBC) and BMI <br/ ><br> <br/ ><br>Timepoint: 2 years